Course curriculum

  • 1

    Endocrine/Metabolic

    • ACE inhibitor and ARB use in diabetes (July 2018)

    • Acid-base disorders (November 2018)

    • Acute pancreatitis (March 2019)

    • Adnexal mass in premenopausal women - 2Qs (November 2019)

    • Alcohol use disorder (July 2018)

    • Alcohol use disorder evaluation (July 2018)

    • Alcohol withdrawal - 4Qs (January 2020)

    • Amenorrhea - Secondary - 2Qs (September 2018)

    • Amyloidosis (March 2019)

    • Aspirin therapy and diabetes (May 2019)

    • Bariatric surgery - 2Qs (March 2019)

    • Compression fractures (November 2019)

    • Contraception and neurologic disease - 2Qs (March 2019)

    • Diabetes in children (November 2020)

    • Diabetes - Diagnosis (September 2018)

    • Diabetic foot osteomyelitis - 3Qs (May 2020)

    • Diabetes - Individualization of medications - 3Qs (November 2019)

    • Diabetic ketoacidosis and euglycemia - 2Qs (January 2020)

    • Diabetes - Perioperative management (May 2020)

    • Diabetes - screening in pregnancy (September 2019)

    • Diabetes - Type 1 in children - 3Qs (September 2020)

    • Diabetes mellitus - Type 1 Pediatric- 2Qs (January 2020)

    • Diabetes - Type 2 in children and adolescents - 3Qs (September 2019)

    • Diabetes mellitus type 2 – prevention - 3Qs (May 2019)

    • Gastroparesis (UPDATED) - 3Qs (May 2020)

    • Gastroparesis - 3Qs (September 2018)

    • Gestational diabetes - 4Qs (September 2018)

    • Glycemic control - 3Qs (May 2019)

    • Gout - prevention - 2Qs (January 2019)

    • Graves disease (September 2018)

    • Gynecomastia - 3Qs (September 2019)

    • Hemoglobin A1C targets (September 2018)

    • Hirsutism in women (November 2019)

    • Hyperglycemia -Medication-induced - 2Qs (September 2019)

    • Hyperglycemia - Corticosteroid-induced - 3Qs (November 2019)

    • Hyperprolactinemia - 2Qs (January 2020)

    • Hypertriglyceridemia - 2Qs (November 2018)

    • Hypoglycemia - Neonatal (September 2019)

    • Hyponatremia - 2Qs (May 2019)

    • Hypoparathyroidism - 2Qs (November 2019)

    • Incretin-based therapy for type 2 diabetes mellitus (July 2018)

    • Lipid screening in children (November 2019)

    • Menstrual migraine - 2Qs (May 2019)

    • Minimal change disease (November 2019)

    • Nephrotic syndrome - 2Qs (January 2019)

    • Prediabetes (November 2018)

    • Prediabetes in adults - 2Qs (May 2020)

    • Pregnancy and obesity (May 2019)

    • Sodium-coupled glucose transporter-2 (SGLT2) inhibitors - 2Qs (March 2019)

    • Subclinical hyperthyroidism (July 2018)

    • Sulfonylurea overdose - 2Qs (November 2019)

    • Thyroid medication – dosing - 2Qs (May 2019)

    • Tranexamic acid (generic, Lysteda) (March 2019)

    • Transgender health care (March 2019)

    • Understanding lipid recommendations - 2Qs (September 2018)

    • Uterine bleeding - Abnormal (September 2018)

    • Uterine bleeding in the adolescent - Abnormal - 3Qs (September 2018)

    • Vitamin B12 deficiency (November 2019)

    • Wilson's disease (March 2019)